Evidence map›Paper›PMID 33693628›Full record

ArticleGenetics2021

Split-wrmScarlet and split-sfGFP: tools for faster, easier fluorescent labeling of endogenous proteins in Caenorhabditis elegans.

Jérôme Goudeau, Catherine S Sharp, Jonathan Paw, Laura Savy, Manuel D Leonetti, Andrew G York, Dustin L Updike, Cynthia Kenyon, Maria Ingaramo

Abstract read
In one paragraph

Article in Genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed.

  1. Review
  2. Article
  3. Functions and trafficking mechanisms of RIC-8 inMolecular biology of the cell · 2026
    Article
  4. Article
  5. Article
  6. Efficient Endogenous Tagging in the Sea Urchin,bioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. PES-8 is required for Cytoskeletal Organization and Contractility in thebioRxiv : the preprint server for biology · 2026
    Article
  11. ER discontinuities are common inbioRxiv : the preprint server for biology · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jérôme GoudeauCalico Life Sciences LLC, South San Francisco, CA 94080, USA.
Catherine S SharpMount Desert Island Biological Laboratory, Bar Harbor, ME 04672, USA.
Jonathan PawCalico Life Sciences LLC, South San Francisco, CA 94080, USA.
Laura SavyChan Zuckerberg Biohub, San Francisco, CA 94158, USA.
Manuel D LeonettiChan Zuckerberg Biohub, San Francisco, CA 94158, USA.
Andrew G YorkCalico Life Sciences LLC, South San Francisco, CA 94080, USA.
Dustin L UpdikeMount Desert Island Biological Laboratory, Bar Harbor, ME 04672, USA.
Cynthia KenyonCalico Life Sciences LLC, South San Francisco, CA 94080, USA.
Maria IngaramoCalico Life Sciences LLC, South San Francisco, CA 94080, USA.

Funding

The Maine Biomedical Research Network (INBRE)P20GM103423 · NIGMS · MOUNT DESERT ISLAND BIOLOGICAL LAB · PI Dustin Lynn Updike · 2012 to 2026
$60.0M
Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Aric L Daul, Ann E. Rougvie · 2012 to 2026
$7.5M
The function of germ granules in maintaining pluripotency in the C. elegans germlineR01GM113933 · NIGMS · MOUNT DESERT ISLAND BIOLOGICAL LAB · PI UPDIKE, DUSTIN LYNN · 2015 to 2023
$3.1M
NIGMS NIH HHS P20 GM103423NIGMS NIH HHS R01 GM113933NIH HHS P40 OD010440
6 · The paper itself

Abstract

We create and share a new red fluorophore, along with a set of strains, reagents and protocols, to make it faster and easier to label endogenous Caenorhabditis elegans proteins with fluorescent tags. CRISPR-mediated fluorescent labeling of C. elegans proteins is an invaluable tool, but it is much more difficult to insert fluorophore-size DNA segments than it is to make small gene edits. In principle, high-affinity asymmetrically split fluorescent proteins solve this problem in C. elegans: the small fragment can quickly and easily be fused to almost any protein of interest, and can be detected wherever the large fragment is expressed and complemented. However, there is currently only one available strain stably expressing the large fragment of a split fluorescent protein, restricting this solution to a single tissue (the germline) in the highly autofluorescent green channel. No available C. elegans lines express unbound large fragments of split red fluorescent proteins, and even state-of-the-art split red fluorescent proteins are dim compared to the canonical split-sfGFP protein. In this study, we engineer a bright, high-affinity new split red fluorophore, split-wrmScarlet. We generate transgenic C. elegans lines to allow easy single-color labeling in muscle or germline cells and dual-color labeling in somatic cells. We also describe a novel expression strategy for the germline, where traditional expression strategies struggle. We validate these strains by targeting split-wrmScarlet to several genes whose products label distinct organelles, and we provide a protocol for easy, cloning-free CRISPR/Cas9 editing. As the collection of split-FP strains for labeling in different tissues or organelles expands, we will post updates at doi.org/10.5281/zenodo.3993663.

Indexed as

AnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsGenetic EngineeringGerm CellsGreen Fluorescent ProteinsLuminescent ProteinsProtein TransportRecombinant ProteinsRed Fluorescent ProteinCaenorhabditis elegans ProteinsGreen Fluorescent ProteinsLuminescent ProteinsRecombinant ProteinsRed Fluorescent ProteinCas9C. elegansCRISPRgenome engineeringgermlineGFPmScarletprotein localizationwrmScarlet

Identifiers

PMID33693628
PMCPMC8049552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.